Indications and Purposes
| 1 Indications And Usage Mektovi ® Is Indicated, In Combination With Encorafenib, For The Treatment Of Patients With Unresectable Or Metastatic Melanoma With A Braf V600e Or V600k Mutation, As Detected By An Fda-Approved Test [See Dosage And Administration (2.1) ] . Mektovi Is A Kinase Inhibitor Indicated, In Combination With Encorafenib, For The Treatment Of Patients With Unresectable Or Metastatic Melanoma With A Braf V600e Or V600k Mutation, As Detected By An Fda-Approved Test. ( 1 , 2.1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Binimetinib |
|
ZINC38460704 |